Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03321266 · ClinicalTrials.gov registry record
Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas
A clinical trial, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- 79
- Enrollment target
NCT03321266: Completed study, sponsored by Cook Group Incorporated.
NCT03321266 is a clinical trial that has completed, run by Cook Group Incorporated. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03321266 has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The study is a retrospective review of the use of the Biodesign® Fistula Plug (C-FPS-\[X\]). A total of 73 patients will be enrolled who have had a fistula plug placed to treat anorectal fistulas and will therefore be eligible for statistical analysis.
Primary Outcome
Absence of drainage from the external fistula opening with complete epithelialization of the external fistula opening upon clinical exam.
Interventions
- DEVICE Cook Biodesign® Fistula Plug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2017-11-30 |
| Est. Completion | 2019-08-29 |
What the finished NCT03321266 record still lists
NCT03321266 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cook Biodesign® Fistula Plug is the first listed.
NCT03321266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03321266 about?
NCT03321266 is a clinical study titled "Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas". The study is a retrospective review of the use of the Biodesign® Fistula Plug (C-FPS-\[X\]). A total of 73 patients will be enrolled who have had a fistula plug placed to treat anorectal fistulas and will therefore be eligible for statistical analysis.
What is the current status of trial NCT03321266?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2017-11-30. Estimated completion is 2019-08-29.
What interventions are being tested in trial NCT03321266?
The interventions under investigation include: Cook Biodesign® Fistula Plug (DEVICE).
Who is sponsoring clinical trial NCT03321266?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI